<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Biogenic Amines and Polypeptides - Pharmacology and Pharmacotherapeutics</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="../styles/main.css">
    
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <!-- Floating Table of Contents -->
    <div class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span>
            <span>Contents</span>
        </div>
        <ul class="floating-toc-list">
            <!-- JS will populate this -->
        </ul>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>üß¨</span>
                        <span>Section V</span>
                    </div>
                    <h1 class="document-title">Other Biogenic Amines and Polypeptides</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Autacoids & Migraine</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>60 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- START: Chapter 23 -->
                    <section class="content-section" id="chapter-23">
                        <div class="section-header">
                            <div class="section-number">23</div>
                            <h2 class="section-title">
                                <span class="title-icon">üêù</span>
                                Histamine and Antihistaminic Drugs
                            </h2>
                        </div>

                        <div class="content-card">
                            <p><strong>Histamine</strong> (Tissue Amine) is an autacoid (local hormone) derived from the amino acid histidine. It is stored in mast cells and basophils along with heparin. It is released during allergic reactions (IgE mediated) and by certain drugs (morphine, tubocurarine).</p>

                            <h3>Histamine Receptors</h3>
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Receptor</th>
                                            <th>Location</th>
                                            <th>Major Effects</th>
                                            <th>Selective Agonist</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>H<sub>1</sub></strong></td>
                                            <td>Smooth muscles (Bronchi, Gut), Endothelium, Brain</td>
                                            <td>Contraction of smooth muscle, Increased vascular permeability, Alertness (CNS).</td>
                                            <td>2-Methylhistamine</td>
                                        </tr>
                                        <tr>
                                            <td><strong>H<sub>2</sub></strong></td>
                                            <td>Gastric parietal cells, Heart, Vessels</td>
                                            <td>Gastric acid secretion, Cardiac stimulation, Vasodilation.</td>
                                            <td>Dimaprit</td>
                                        </tr>
                                        <tr>
                                            <td><strong>H<sub>3</sub></strong></td>
                                            <td>Presynaptic (Brain)</td>
                                            <td>Inhibition of neurotransmitter release (Autoreceptor).</td>
                                            <td>(R)-alpha-methylhistamine</td>
                                        </tr>
                                        <tr>
                                            <td><strong>H<sub>4</sub></strong></td>
                                            <td>Eosinophils, Mast cells</td>
                                            <td>Chemotaxis.</td>
                                            <td>-</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <div class="callout callout--info">
                                <div class="callout-header">
                                    <span class="callout-icon">üî¥</span>
                                    <h4 class="callout-title">Triple Response of Lewis</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Intradermal injection of histamine produces:</p>
                                    <ol>
                                        <li><strong>Red Spot:</strong> Local vasodilation (Direct action).</li>
                                        <li><strong>Wheal:</strong> Edema due to increased permeability.</li>
                                        <li><strong>Flare:</strong> Diffuse redness due to axon reflex.</li>
                                    </ol>
                                </div>
                            </div>

                            <h3>H<sub>1</sub> Receptor Antagonists (Antihistamines)</h3>
                            <p>These drugs competitively block the effects of histamine at H<sub>1</sub> receptors. They do not block H<sub>2</sub> receptors (gastric acid secretion).</p>

                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>First Generation (Classical)</h4>
                                    <p>Lipid soluble, cross BBB. Cause <strong>Sedation</strong> and have <strong>Anticholinergic</strong> effects.</p>
                                    <ul>
                                        <li><strong>Diphenhydramine:</strong> Potent sedative, anticholinergic. Used in motion sickness.</li>
                                        <li><strong>Promethazine:</strong> Potent sedative, anti-emetic.</li>
                                        <li><strong>Chlorpheniramine:</strong> Less sedating. Common in cold remedies.</li>
                                        <li><strong>Cyclizine/Meclizine:</strong> Anti-vertigo/Motion sickness.</li>
                                        <li><strong>Cyproheptadine:</strong> Also blocks 5-HT. Used as appetite stimulant.</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Second Generation (Newer)</h4>
                                    <p>Do not cross BBB significantly. <strong>Non-sedating</strong>. No anticholinergic side effects.</p>
                                    <ul>
                                        <li><strong>Cetirizine:</strong> Active metabolite of hydroxyzine. Minimal sedation.</li>
                                        <li><strong>Levocetirizine:</strong> Active isomer of cetirizine.</li>
                                        <li><strong>Loratadine:</strong> Long acting. No sedation.</li>
                                        <li><strong>Fexofenadine:</strong> Metabolite of terfenadine (non-cardiotoxic).</li>
                                        <li><strong>Azelastine:</strong> Topical (Nasal spray/Eye drops).</li>
                                    </ul>
                                </div>
                            </div>

                            <p><strong>Therapeutic Uses:</strong></p>
                            <ul>
                                <li>Allergic disorders (Urticaria, Rhinitis, Hay fever).</li>
                                <li>Common cold (Palliative).</li>
                                <li>Motion Sickness (Promethazine, Diphenhydramine).</li>
                                <li>Vertigo (Cinnarizine, Betahistine).</li>
                                <li>Sedative/Hypnotic (Promethazine in children).</li>
                                <li>Parkinsonism (Anticholinergic property).</li>
                            </ul>

                            <p><strong>Betahistine:</strong> H<sub>1</sub> agonist and H<sub>3</sub> antagonist. Increases cochlear blood flow. Drug of choice for <strong>Meniere's disease</strong>.</p>
                        </div>
                    </section>
                    <!-- END: Chapter 23 -->

                    <!-- START: Chapter 24 -->
                    <section class="content-section" id="chapter-24">
                        <div class="section-header">
                            <div class="section-number">24</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü§ï</span>
                                5-HT (Serotonin) and Migraine
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>5-Hydroxytryptamine (Serotonin)</h3>
                            <p>Found in Enterochromaffin cells (90%), Platelets, and CNS. It is synthesised from Tryptophan. Metabolised by MAO-A into 5-HIAA (diagnostic marker for Carcinoid syndrome).</p>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Receptor</th>
                                            <th>Mechanism</th>
                                            <th>Clinical Importance</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>5-HT<sub>1</sub></strong></td>
                                            <td>Gi (Inhibitory)</td>
                                            <td><strong>1A:</strong> Buspirone (Anxiety).<br><strong>1B/1D:</strong> Triptans (Migraine).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>5-HT<sub>2</sub></strong></td>
                                            <td>Gq (Excitatory)</td>
                                            <td>Platelet aggregation, Smooth muscle contraction. Blocked by Cyproheptadine, Ketanserin.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>5-HT<sub>3</sub></strong></td>
                                            <td>Ion Channel</td>
                                            <td>CTZ (Vomiting). Blocked by Ondansetron.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>5-HT<sub>4</sub></strong></td>
                                            <td>Gs (Excitatory)</td>
                                            <td>GI Motility. Stimulated by Cisapride/Mosapride (Prokinetics).</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Pharmacotherapy of Migraine</h3>
                            <p>Migraine is a pulsatile, hemicranial headache often associated with nausea, vomiting, and photophobia. Pathophysiology involves initial vasoconstriction (aura) followed by excessive vasodilatation (headache) of cranial vessels, and neurogenic inflammation.</p>

                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>Treatment of Acute Attack (Abortive)</h4>
                                    <ul>
                                        <li><strong>Mild/Moderate:</strong> NSAIDs (Aspirin, Paracetamol, Ibuprofen) + Antiemetic (Metoclopramide).</li>
                                        <li><strong>Moderate/Severe:</strong>
                                            <ul>
                                                <li><strong>Triptans (Sumatriptan, Rizatriptan):</strong> Selective 5-HT<sub>1B/1D</sub> agonists. Cause constriction of dilated cranial vessels and inhibit neurogenic inflammation. <em>Contraindicated in Ischaemic Heart Disease.</em></li>
                                                <li><strong>Ergot Alkaloids (Ergotamine):</strong> Non-selective 5-HT agonists + $\alpha$ adrenergic action. Potent vasoconstrictor. Risk of gangrene with overdose.</li>
                                            </ul>
                                        </li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Prophylaxis (Prevention)</h4>
                                    <p>Indicated if attacks are frequent (>2-3/month) or severe.</p>
                                    <ul>
                                        <li><strong>Beta-blockers:</strong> Propranolol (Drug of Choice).</li>
                                        <li><strong>Calcium Channel Blockers:</strong> Flunarizine.</li>
                                        <li><strong>Anticonvulsants:</strong> Topiramate, Valproate.</li>
                                        <li><strong>Antidepressants:</strong> Amitriptyline (TCA).</li>
                                        <li><strong>5-HT Antagonists:</strong> Pizotifen.</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: Chapter 24 -->

                    <!-- START: Chapter 25 -->
                    <section class="content-section" id="chapter-25">
                        <div class="section-header">
                            <div class="section-number">25</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¨</span>
                                Eicosanoids and Other Autacoids
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Angiotensin</h3>
                            <p><strong>Renin-Angiotensin System (RAS):</strong> Renin (kidney) converts Angiotensinogen to Angiotensin I. ACE (lungs) converts Angiotensin I to <strong>Angiotensin II</strong> (Potent vasoconstrictor, releases Aldosterone).</p>
                            <p><strong>Angiotensin Antagonists:</strong></p>
                            <ul>
                                <li><strong>ACE Inhibitors:</strong> Captopril, Enalapril (See Chapter 30).</li>
                                <li><strong>AT<sub>1</sub> Receptor Blockers (ARBs):</strong> Losartan, Valsartan.</li>
                            </ul>

                            <h3>Kinins (Bradykinin)</h3>
                            <p>Potent vasodilator, increases capillary permeability, and causes pain. Metabolised by Kininase II (same as ACE). ACE inhibitors increase bradykinin levels $\to$ Dry cough/Angioedema.</p>

                            <h3>Prostaglandins (PGs) and Leukotrienes (LTs)</h3>
                            <p>Derived from membrane phospholipid <strong>Arachidonic Acid</strong>.</p>
                            <div class="callout callout--info">
                                <div class="callout-header">
                                    <span class="callout-icon">üîÑ</span>
                                    <h4 class="callout-title">Biosynthesis Pathways</h4>
                                </div>
                                <div class="callout-content">
                                    <ul>
                                        <li><strong>Cyclooxygenase (COX) Pathway:</strong> Prostaglandins (PGE<sub>2</sub>, PGF<sub>2$\alpha$</sub>), Prostacyclin (PGI<sub>2</sub>), Thromboxane (TXA<sub>2</sub>). Inhibited by NSAIDs.</li>
                                        <li><strong>Lipoxygenase (LOX) Pathway:</strong> Leukotrienes (LTB<sub>4</sub>, LTC<sub>4</sub>, LTD<sub>4</sub>). Involved in Asthma. Inhibited by Zileuton.</li>
                                    </ul>
                                </div>
                            </div>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Eicosanoid</th>
                                            <th>Major Actions</th>
                                            <th>Clinical Analogue/Antagonist</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>PGE<sub>2</sub></strong></td>
                                            <td>Vasodilation, Uterine contraction, Gastric mucus secretion (cytoprotection), Fever, Pain.</td>
                                            <td><strong>Dinoprostone</strong> (Induction of labour/abortion).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>PGE<sub>1</sub></strong></td>
                                            <td>Vasodilation, Patency of Ductus Arteriosus.</td>
                                            <td><strong>Misoprostol</strong> (Peptic ulcer, Abortion). <strong>Alprostadil</strong> (Erectile dysfunction).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>PGF<sub>2$\alpha$</sub></strong></td>
                                            <td>Uterine contraction, Uveoscleral outflow (eyes).</td>
                                            <td><strong>Carboprost</strong> (PPH). <strong>Latanoprost</strong> (Glaucoma).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>PGI<sub>2</sub> (Prostacyclin)</strong></td>
                                            <td>Inhibits platelet aggregation, Vasodilation.</td>
                                            <td><strong>Epoprostenol</strong> (Pulmonary hypertension, Dialysis).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>TXA<sub>2</sub> (Thromboxane)</strong></td>
                                            <td>Promotes platelet aggregation, Vasoconstriction.</td>
                                            <td>Inhibited by <strong>Aspirin</strong>.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Leukotrienes (C4/D4)</strong></td>
                                            <td>Potent Bronchoconstriction.</td>
                                            <td><strong>Montelukast/Zafirlukast</strong> (Receptor antagonists for Asthma).</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </section>
                    <!-- END: Chapter 25 -->

                    <aside class="key-points-section" role="region" aria-labelledby="key-points-title">
                        <div class="key-points-wrapper">
                            <div class="key-points-header">
                                <span class="key-points-icon">‚≠ê</span>
                                <h3 id="key-points-title" class="key-points-title">Section V Key Points</h3>
                            </div>
                            <ul class="key-points-list">
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Second generation antihistamines</strong> (e.g., Cetirizine) are preferred for allergy as they lack sedation and anticholinergic effects.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Sumatriptan</strong> (5-HT<sub>1B/1D</sub> agonist) is the specific drug for acute severe migraine; <strong>Propranolol</strong> is for prophylaxis.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Misoprostol</strong> (PGE<sub>1</sub>) is used for NSAID-induced ulcers and medical abortion.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Latanoprost</strong> (PGF<sub>2$\alpha$</sub> derivative) is a first-line drug for wide-angle glaucoma.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Montelukast</strong> blocks leukotriene receptors and is useful in bronchial asthma.</p>
                                </li>
                            </ul>
                        </div>
                    </aside>
                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="section-04.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Section IV: Autonomic Nervous System</div>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>5</span>
                                <span class="progress-separator">/</span>
                                <span>16</span>
                            </div>
                        <a href="../index.html" class="nav-button nav-button--large">
                            <div class="nav-label">Go to</div>
                            <div class="nav-title">Index</div>
                        </a>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 31.25%;"></div>
                            </div>
                            <div class="progress-label">Section 5 of 16</div>
                        </div>
                        
                        <a href="section-06.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Section VI: Respiratory Drugs</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>